BridgeBio Pharma Inc
BBIO
Market Cap$4.74B
Close$
$-9.06
135.9% downside
Current Fair Value
135.9% downsideOvervalued by 135.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.74 Billion |
|---|---|
| Enterprise Value | $4.38 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-3.95 |
| Beta | 1.08 |
| Outstanding Shares | 187,586,680 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -10.43 |
|---|---|
| PEG | 19.5 |
| Price to Sales | 25.23 |
| Price to Book Ratio | 8.41 |
| Enterprise Value to Revenue | 19.99 |
| Enterprise Value to EBIT | -8.73 |
| Enterprise Value to Net Income | -10 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | -0.04 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About BridgeBio Pharma Inc
CEO: Neil Kumar